Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 1,500 shares of Plexus stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $252.77, for a total value of $379,155.00. Following the completion of the transaction, the chief executive officer owned 72,388 shares in the company, valued at $18,297,514.76. This represents a 2.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Plexus Stock Up 3.6%
Shares of NASDAQ PLXS traded up $9.34 during mid-day trading on Friday, reaching $265.72. 226,814 shares of the company were exchanged, compared to its average volume of 343,209. Plexus Corp. has a 1 year low of $115.35 and a 1 year high of $275.83. The firm has a 50-day moving average of $228.85 and a 200 day moving average of $189.62. The stock has a market cap of $7.11 billion, a price-to-earnings ratio of 38.85 and a beta of 0.88. The company has a quick ratio of 0.74, a current ratio of 1.54 and a debt-to-equity ratio of 0.06.
Plexus (NASDAQ:PLXS – Get Free Report) last posted its earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The company had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same quarter in the previous year, the firm earned $1.66 earnings per share. The firm’s quarterly revenue was up 18.7% compared to the same quarter last year. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. On average, research analysts expect that Plexus Corp. will post 5.97 earnings per share for the current year.
Institutional Investors Weigh In On Plexus
Analysts Set New Price Targets
Several equities research analysts have weighed in on PLXS shares. Needham & Company LLC raised their target price on shares of Plexus from $206.00 to $285.00 and gave the company a “buy” rating in a research note on Friday, May 1st. Zacks Research lowered Plexus from a “hold” rating to a “strong sell” rating in a report on Wednesday. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Benchmark restated a “buy” rating and set a $220.00 target price on shares of Plexus in a research note on Monday, March 16th. Finally, Stifel Nicolaus set a $250.00 price target on Plexus and gave the company a “buy” rating in a research note on Monday, April 20th. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $229.17.
View Our Latest Report on PLXS
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
See Also
- Five stocks we like better than Plexus
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
